Skip to main content
Premium Trial:

Request an Annual Quote

StageZero Life Sciences, DiagnoseAtHome Partner on Multicancer Blood Test

NEW YORK — StageZero Life Sciences said on Wednesday that it has signed an agreement to offer its Aristotle multicancer blood test in the US and Canada through DiagnoseAtHome, an online provider of at-home health and lab testing services.

Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types including breast, liver, stomach, and bladder cancers in a single blood sample. The test is processed through StageZero's CLIA-certified lab.

Financial and other terms of the deal were not disclosed.

"Our partnership with DiagnoseAtHome allows greater access to early cancer screening for their many clients and broadens the availability of Aristotle in Canada and the USA," StageZero Chairman and CEO James Howard-Tripp said in a statement.

Earlier this year, Toronto-based StageZero closed a C$1.87 million (US$1.46 million) private financing.

The Scan

Nature Papers on Long Reads for Bacterial Genomes, Zebrafish Atlas, Hypothalamic Aging in Mammals

In Nature this week: near-finished microbial genomes without polishing, zebrafish functional annotation program, and more. 

Rise of BA.5

The New York Times reports that the Omicron subvariant BA.5 has become the dominant version of SARS-CoV-2 in the US.

UK Health Secretary Resigns

Sajid Javid, the UK health secretary, resigned along with Chancellor Rishi Sunak, saying they cannot work with Prime Minister Boris Johnson's government, CNN reports.

Clones From Freeze-Dried Cells

A team in Japan has cloned mice from freeze-dried skin cells, according to the Guardian.